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Abstract
Background
We report the use of an ex vivo precision cut liver slice (PCLS) mouse model for studying
hepatic schistosomiasis. In this system, liver tissue is unfixed, unfrozen, and alive for main-
tenance in culture and subsequent molecular analysis.
Methods and Findings
Using thick naive mouse liver tissue and sterile culture conditions, the addition of soluble
egg antigen (SEA) derived from Schistosoma japonicum eggs, followed 4, 24 and 48hrs
time points. Tissue was collected for transcriptional analysis and supernatants collected to
quantitate liver enzymes, cytokines and chemokines. No significant hepatotoxicity was
demonstrated by supernatant liver enzymes due to the presence of SEA. A proinflammatory
response was observed both at the transcriptional level and at the protein level by cytokine
and chemokine bead assay. Key genes observed elevated transcription in response to the
addition of SEA included: IL1-α and IL1-β, IL6, all associated with inflammation. The recruit-
ment of antigen presenting cells was reflected in increases in transcription of CD40, CCL4
and CSF1. Indications of tissue remodeling were seen in elevated gene expression of vari-
ous Matrix MetalloProteinases (MMP3, 9, 10, 13) and delayed increases in TIMP1. Colla-
gen deposition was significantly reduced in the presence of SEA as shown in COL1A1
expression by qPCR after 24hrs culture. Cytokine and chemokine analysis of the culture su-
pernatants confirmed the elevation of proteins including IL6, CCL3, CCL4 and CXCL5.
Conclusions
This ex vivomodel system for the synchronised delivery of parasite antigen to liver tissue
provides an insight into the early phase of hepatic schistosomiasis, corresponding with the
release of soluble proteins from dying schistosome eggs.
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Author Summary
Schistosomiasis is a major disease of humans caused by schistosome blood flukes. One of
the primary sites of pathology is the liver of the infected host, and it is caused by the depo-
sition of parasite eggs leading to an immune-fibrotic response. We have used an animal
tissue model for this disease, where slices of liver of uniform thickness are used in culturing
experiments with the addition of parasite egg protein from the species Schistosoma japoni-
cum. We found over the 48 hours tissue was exposed to egg proteins, gene associated with
important immunological responses including inflammation and antigen processing were
up-regulated. Similarly, responses in tissue remodeling and the modulation of genes in-
volved in fibrosis were also indicated. In this study we were able to characterise the initial
responses of host liver tissue when exposed to parasite protein released by dying eggs, rep-
resenting one of the early phases of hepatic schistosomiasis in an ex vivomodel.
Introduction
The major neglected tropical disease schistosomiasis is caused by parasitic helminth worms of
the genus Schistosoma. The disease affects 200 million people worldwide with many more at
risk. The clinical features of schistosomiasis range from fever, headache and lethargy, to severe
liver inflammation, liver scarring (collagen deposition and fibrosis), and organ failure. Within
host tissues containing trapped schistosome eggs, extensive fibrosis occurs but, paradoxically,
the immediate area surrounding the eggs themselves remains unaffected [1–3].
The granulomatous reaction and general immune reaction induced by schistosome egg
trapped within host tissues, is the primary etiology of schistosomiasis [4]. While granulomas
arise to destroy the eggs and sequester or neutralise otherwise pathogenic egg antigens, this
process also leads to extensive fibrosis of host tissues [5]. Schistosome eggs can survive at most
for a few weeks in host tissue [6], after which their soluble protein contents are released. The
majority of pathology resulting from S.mansoni or S. japonicum infections develops at the site
of maximal egg accumulation: the liver [7]. In schistosomiasis, host liver pathology is induced
by a CD4+Th2-driven granulomatous response directed against schistosome eggs and the mol-
ecules they release when lodged in host tissues. The Th2 cytokines IL-4 and IL-13 drive this re-
sponse, while IL-10, IL13R-α2, IFN-γ, and a subset of regulatory T-cells and alternatively
activated macrophages, act to limit the schistosome-induced pathology. The majority of these
observations were made using mouse models for schistosomiasis with egg deposition in the
liver staggered over weeks. Coordinated egg deposition is possible using the pulmonary granu-
loma model [8], which also controls the amount of antigen introduced to the animal but not
the distribution of antigen across the organ, which in this case is obviously the lung, not the
normal site of pathology, the liver. We have adopted the precision cut liver slice technique [9]
which provides an ex vivo system that allows the consistent concentration of parasite antigen
across the entire tissue section in a synchronized manner and permits the collection of tissue
through a time course.
The Hepatic Stellate Cell (HSC) is normally a quiescent non-parenchymal cell located in the
space of Dissé of the liver sinusoid. Upon insult or injury to the liver, HSCs undergo a process
of transdifferentiation (activation) into a fibrogenic myofibroblast responsible for the produc-
tion of collagen and the formation of scar-like matrix (fibrosis). The HSC plays a significant
role in fibrotic schistosomiasis, as shown in both murine and human infections of S. japonicum
[10] and human S.mansoni infections [11].
An Ex VivoModel for Hepatic Schistosomiasis
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In recent studies we and others have co-cultured HSCs with schistosome eggs (separated by
transwells), and measured known markers of transdifferentiation, which demonstrated that
cells remained in, or were returned to, a quiescent state [12,13]. Even in the presence of TGF-β,
the down-regulation of fibrosis-related genes, αSMA and procollagen α1(I), and the up-regula-
tion of PPARγ, which is associated with quiescence, was observed in HSCs [12]. TGF-β is a
strong inducer of profibrotic genes resulting in HSC activation. The ability of schistosome eggs
to attenuate this strong profibrotic effect of TGF-β is a significant observation and supports the
hypothesis that an egg molecular component could be used to treat active fibrotic disease. This
down-regulation of fibrosis associated genes could explain why collagen deposition is observed
only at the periphery of the granuloma distal to the location of the eggs and why fibrosis only
occurs throughout the granuloma area after an egg has been destroyed. While recent work by
others using primary HSCs and S. japonicum soluble egg antigen (SEA) reported an increase in
cell activation [14], this study did not control for the presence of LPS (lipopolysaccharide) and
used SEA concentrations 20–50 times higher than we have employed [13]; moreover a second
research group has now confirmed our anti-fibrotic phenotype in primary HSCs using LPS-
free S. japonicum SEA [15].
To further characterise this phenotype we have used SEA with an ex vivo precision cut liver
slice (PCLS) mouse model, and whole genome transcriptomics. The use of SEA is relevant as it
replicates the released proteins from dying schistosome eggs and is a protein mixture distinct
from excreted/secreted (ES) products actively released from live eggs. The tissue slice culture
model of naïve murine liver allows the investigation of local responses of a mixture of hepatic
cells (HSCs, hepatocytes and Kupffer cells (KCs)) to egg bioactive molecules, better replicating
the in vivo liver microenvironment, and determining how early molecular events may contrib-
ute to the eventual granulomatous response. Similar approaches using PCLS have been success-
fully employed in studies of liver metabolism and toxicity [16,17]. Fibrosis has also been
investigated using tissue slices of liver, predominantly using chemical or surgical methods (see
[18] for review). However the application of ex vivomodel to investigate innate immunity and
tissue remodeling in the liver, in response to a major human pathogen, is a novel approach.
Materials and Methods
Ethics statement
All work was conducted with the approval of the Animal Ethics Committee of the QIMR Ber-
ghofer Medical Research Institute (Project Number 288), which adheres to the Australian code
of practice for the care and use of animals for scientific purposes, as well as the Queensland An-
imal Care and Protection Act 2001; Queensland Animal Care and Protection Regulation 2002.
Parasite lifecycle and antigen collection
The S. japonicum life cycle is currently maintained at QIMR Berghofer in female Swiss mice in-
fected with a Chinese mainland, Anhui population, strain. Live schistosome eggs were isolated
from the livers of murine hosts as previously described [12]. Isolated S. japonicum eggs were
homogenised (twice using 5 mm beads) using tissue lyser (Qiagen) for 1 min each at 25 Hertz.
The subsequent homogenate was checked microscopically to ensure the complete rupturing of
eggs. The homogenate was then centrifuged 10,000 g for 2hrs at 4°C and the supernatant col-
lected. All egg antigen preparations (SEA) were shown to be lipopolysaccharide (LPS)-free by
the Limulus Amebocyte Lysate (0.06 EU/ml) assay (Lonza, Australia).
Mice (naïve female C57BL/6, 5–6 weeks old) were euthanised by cervical dislocation and in-
tact livers removed. A portion of liver was collected at this point and was designated pre-cut
[PC]. An additional ~1cm3 piece of liver was collected and a refrigerated macro tissue slicer
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(WPI model SYS-NVSLM1 Motorized Vibroslice) was used to cut 250 μm sections of mouse
liver (slices), which were then cultured in William’s Medium E containing 25 mM glucose, 10
mg/ml gentamycin and 10% (v/v) FBS [16], for 2 hours to allow the tissue to rest. Then, SEA
was added to the cultured hepatic tissue slices at 10 μg/ml (concentration based on [12] and
[2,19]) for a total of 48hrs; negative controls included no added SEA protein. The SEA concen-
tration used was also indicative of the amount of SEA we isolate from an infected mouse liver,
and the tissue volume the granuloma is contained within the organ. Tissue sections were then
collected after 0 (prior to SEA addition), 4, 24 and 48hrs and tissue processed for transcription-
al analyses. Four biological replicates (liver slices from 4 separate mice) were examined for all
of the methods listed below.
Hepatotoxicity assay
Hepatotoxicity was determined by assessing lipid peroxidation using a malondialdehyde
(MDA) Assay Kit (BioVision, San Francisco USA) using the media sampled at each time point
[20]. Quantification of MDA is reflective of oxidative stress, with the formation of MDA being
one of the by-products of lipid peroxidation [20]. The absorbance at 532nm was measured
after the formation of MDA-TAA (Thiobarbituric Acid) adducts using the manufacturer’s
standard protocol.
Microarray analysis: cRNA synthesis and whole genome microarray
hybridisation
cRNA was synthesised from total RNA for each sample using Illumina Total Prep RNA ampli-
cation kits (Ambion). Biotin-labeled cRNA was hybridised to Illumina Mouse Ref-8 Version 2
whole genome expression arrays, which were then scanned using an Illumina BeadStation
(Illumina).
Microarray analysis: Feature extraction and data analysis
Quality control of microarray data involved the checking of signal-intensity histograms for
hybridisation efficiency and experimental noise using GenomeStudio (Illumina), represented
as a detection score. Further quality control is termed “Flags” and is calculated on a gene specif-
ic basis; it reflects the internal quality controls that are used by microarray manufacturers, con-
sidering both the hybridisation and scanning phases, and the overall fidelity of the extracted
data. All subsequent analysis was performed using GeneSpring GX Version 12.5, and expres-
sion data were normalised to the median of all samples. Gene lists were first normalised to un-
infected controls and filtered for Flags and signal significance based on the detection score of
d 0.95 (which equates to a confidence value of P0.05). All gene expression data are publicly
available through NCBI’s Gene Expression Omnibus; Series Accession Number: GSE64071
and Platform Number: GPL6885.
One-way ANOVA with Benjamini-Hochberg correction for multiple testing was then used
to identify genes differentially expressed (P0.05) over the entire time-course [2]. Alternative-
ly, a moderated t-test with multiple testing correction p0.05 (Benjamin-Hochberg) was used
to identify differentiated expression based on the presence of S. japonicum SEA. The filtered
microarray data provided the basis for ranking genes derived from fold changes and signifi-
cance values. Ingenuity pathway analysis was used to identify diseases and biofunctions or ca-
nonical pathways that were over-represented by the differentially expressed genes [21].
Network analysis (IPA- Ingenuity Pathway Analysis) was performed to create an overview of
the main signalling processes occurring in the SEA exposed liver slices. Up-stream regulator
analysis was performed to identify common upstream factors (e.g., transcription factors or
An Ex VivoModel for Hepatic Schistosomiasis
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drugs) which could be regulating the observed response. Fold changes were represented as
treated (with SEA) relative to untreated samples and p-values associated with these fold
changes calculated from non-averaged time point and treatment groups. A moderated T-test
with no-multiple testing correction was employed to statistically compare fold changes be-
tween treated and untreated samples at each time point (since n = 4 for biological replicates).
Real-time PCR
cDNA was synthesised from total RNA using a Quantitect reverse transcription kit (Qiagen),
and cDNA concentrations were quantified using a Nanodrop-1000 spectrophotometer. Real-
time PCR was performed to validate a subset of microarray data. Primers for quantitative
RT-PCR were sourced from the literature [22–26] or designed using Primer 3 software (S1
Table). Real-time data were normalised to the housekeeping gene, hypoxanthine phosphoribo-
syltranferase (HPRT), as reported previously [27]. Real-time PCR was performed using SYBR
Green master mix (Applied Biosystems) on a Corbett Rotor Gene 6000 (Corbett Life Sciences).
Data from the microarray and real time PCR analyses were examined to ascertain if they fitted
normal distributions using the D'Agostino and Pearson omnibus and the Shapiro-Wilk nor-
mality tests. Statistical analyses were conducted using GraphPad Prism V6.05 or Microsoft
Excel.
Analysis of culture supernatant
Cytokine and chemokine levels were detected from culture supernatant using the Legendplex
Mouse Proinflammatory Chemokine Capture Beads and Mouse Th cytokine Capture Beads
multi-analyte flow assay kits (Biolegend) as per manufacturer’s instructions. The Chemokine
Capture Beads measured CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, CXCL1, CXCL5,
CCL22, CXCL9, CXCL10 and CXCL13. The Th Cytokine Capture Beads measured IL-2, IL-4,
IL-5, IL-6, IL-9, IL-10, IL-13, IL-17A, IL-17F, IL-21, IL-22, IFN-γ and TNF-α. Data were col-
lected on a Fortessa five laser flow cytometer (Becton Dickinson), and analysed using FCAP
Array software (Becton Dickinson).
Results
MDA assay
There was an increase in the MDA content of the media of cultured liver slices over the course
of the observed 48hrs; however the addition of SEA did not result in greater hepatotoxicity
when compared with controls (P value>0.05) (Fig 1).
Transcriptional findings
Filtering of microarray data started with the complete 48,803 probes which were then filtered
for flags (8/32 samples) reducing the number to 22,902. We then applied filters for detection
score (d0.95 equivalent of p-value0.05,8/32 samples) reducing the list to 13,746 probes
(S2 Table). Correlation between individual samples using the 13,746 probes within biological
replicates demonstrated a low level of variation r2 = 0.965–0.985 (Fig 2). Correlation between
individual time points when compared to pre-cut tissue, resulted in r2 = 0.97 for time point 0
(after cutting and 2 hours rest), 0.88 after 4 hours, 0.73 after 24 hours and 0.57 after 48 hours.
This indicates the degree that gene expression of tissue sliced liver varied from that of whole in-
tact tissue, over the 48 hours in culture. Differential expression due to the time course culturing
conditions, using 13,746 probes and 1-way ANOVA with multiple testing correction p0.05
An Ex VivoModel for Hepatic Schistosomiasis
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(Benjamin-Hochberg), found that the majority of genes were affected as seen in 12,068 probes
(S2 Table Column L). No further analysis of this gene list was undertaken.
A moderated t-test with multiple testing correction p0.05 (Benjamin-Hochberg) was used
to identify differential expression based on the presence of SEA, i.e. treated versus untreated,
reducing 13,746 probes to 48 individual genes (Table 1). While 1-way ANOVA based on time
retained the majority of genes, indicating that most genes were differentially expressed due to
being in culture, a much smaller number of genes were changed due to the presence of SEA. Of
the 48 differentially expressed genes attributed to the presence of SEA, the largest increases in
Fig 1. Malondialdehyde (MDA) assay of culture media containing liver slice tissue exposed or not to
soluble egg antigen (SEA).While MDA concentrations in media increased over the 48 hour time course,
indicating hepatotoxicity, there was no statistical difference between treatment groups at any time point (p-
value>0.05).
doi:10.1371/journal.pntd.0003760.g001
Fig 2. Correlation of 13,746 genes identified after quality control filtering.Colouring ranging from r2 =
0.6 for black to r2 = 1 red. Individual samples are grouped by time point and correlation between biological
replicates varied between r2 = 0.965–0.985. Correlation between individual time points with pre-cut (whole)
tissue resulted in r2 = 0.97 for time point 0 (after cutting and 2 hours rest), 0.88 after 4 hours, 0.73 after 24
hours and 0.57 after 48 hours.
doi:10.1371/journal.pntd.0003760.g002
An Ex VivoModel for Hepatic Schistosomiasis
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Table 1. All 48 genes differentially expressed in response to S. japonicum soluble egg antigen (SEA).
FC SEA / control (hours)
Symbol 4 p-Value 24 p-Value 48 p-Value Deﬁnition
il1b 5.2 7.66E-09 4.1 4.15E-09 10.7 8.41E-18 interleukin-1- beta
fpr2 2.7 6.91E-06 3.5 7.53E-07 6.8 4.21E-15 formyl peptide receptor 2
il1a 2.4 1.16E-05 3.3 2.48E-06 4.3 2.73E-11 interleukin-1-alpha
saa3 1.1 3.61E-01 1.9 4.94E-02 3.6 2.69E-08 serum amyloid A 3
cxcl2 2.5 2.52E-04 1.4 3.88E-04 2.8 3.68E-09 chemokine (C-X-C motif) ligand 2
irak3 1.2 8.93E-03 1.8 9.76E-05 2.5 3.64E-08 interleukin-1 receptor-associated kinase 3
ccl3 2.8 5.90E-06 2.3 3.50E-09 2.4 1.46E-08 chemokine (C-C motif) ligand 3
s100a8 1.0 2.54E-01 2.5 6.33E-06 2.3 4.83E-09 S100 calcium binding protein A8
ms4a7 1.1 6.46E-02 1.3 2.38E-03 2.0 9.47E-08 membrane-spanning 4-domains, subfamily A, member 7
fpr1 1.0 3.89E-01 1.5 1.98E-04 1.8 3.85E-06 formyl peptide receptor 1
tlr2 1.3 1.41E-02 1.3 9.44E-04 1.8 4.91E-06 toll-like receptor 2
ccl4 2.0 2.27E-02 1.5 3.98E-03 1.6 5.95E-04 chemokine (C-C motif) ligand 4
h2-m2 1.0 7.29E-01 1.7 3.32E-05 1.6 3.03E-05 histocompatibility 2, M region locus 2
cd207 1.7 8.02E-06 1.3 1.99E-03 1.5 5.36E-03 CD207 antigen
fyb 1.0 7.36E-01 1.5 5.59E-05 1.5 3.64E-04 FYN binding protein
clecsf9 1.5 4.26E-05 2.0 2.86E-06 1.4 1.16E-03 C-type lectin domain superfamily member 9
e330036i19rik 1.2 3.52E-02 1.2 3.40E-03 1.4 5.26E-04 RIKEN cDNA E330036I19 gene
pla2g15 1.0 5.21E-01 1.4 4.24E-05 1.4 3.27E-04 phospholipase A2, group XV
tiam1 1.0 3.87E-01 1.1 1.98E-01 1.4 2.09E-04 T-cell lymphoma invasion and metastasis 1
tnip1 1.6 5.77E-03 1.3 6.00E-04 1.4 2.39E-04 TNFAIP3 interacting protein 1
traf1 1.2 1.08E-02 1.6 2.77E-06 1.4 8.16E-04 Tnf receptor-associated factor 1
cd40 1.6 8.85E-01 1.5 2.35E-01 1.3 3.05E-01 CD40 antigen
ebi3 1.0 3.37E-01 1.2 2.42E-03 1.3 4.24E-03 Epstein-Barr virus induced gene 3
gpr84 1.1 8.53E-02 1.5 1.27E-04 1.3 2.47E-02 G protein-coupled receptor 84
mmp13 5.0 1.03E-06 1.9 6.39E-02 1.3 1.64E-01 matrix metallopeptidase 13
osm 1.0 9.90E-01 1.1 4.74E-02 1.3 4.28E-03 oncostatin M
pilrb1 1.0 2.54E-01 1.3 2.22E-03 1.3 5.05E-03 paired immunoglobin-like type 2 receptor beta 1
ppnr 1.1 1.22E-01 1.2 3.50E-02 1.3 3.97E-03 per-pentamer repeat gene
spic 1.1 4.88E-01 1.3 7.35E-03 1.3 9.31E-02 Spi-C transcription factor
tcf7l2 1.0 2.67E-01 1.1 1.49E-02 1.3 1.29E-03 transcription factor 7-like 2, T-cell speciﬁc, HMG-box
tnfaip2 1.4 8.97E-03 1.0 9.09E-01 1.3 4.32E-02 tumor necrosis factor, alpha-induced protein 2
2610027c15rik 1.2 1.76E-02 1.1 2.12E-01 1.2 2.07E-02 RIKEN cDNA 2610027C15 gene
adora2b 1.2 4.70E-03 1.3 7.90E-04 1.2 5.89E-02 adenosine A2b receptor
arg2 1.0 2.15E-01 1.2 4.86E-02 1.2 6.08E-02 arginase type II
cd33 1.0 7.87E-01 1.4 7.39E-06 1.2 1.95E-02 CD33 antigen
ﬂrt3 1.0 3.51E-01 1.4 8.03E-03 1.2 4.11E-02 ﬁbronectin leucine rich transmembrane protein 3
loc100048721 1.1 1.70E-01 1.3 5.34E-03 1.2 4.41E-02 similar to ﬁbronectin leucine rich transmembrane protein 3
slco3a1 1.2 4.29E-01 1.2 2.00E-01 1.2 8.91E-01 solute carrier organic anion transporter family, member 3a1
zdhhc14 1.1 1.28E-01 1.1 8.25E-02 1.2 3.52E-02 zinc ﬁnger, DHHC domain containing 14
clec4e 1.3 3.23E-03 1.4 6.68E-04 1.1 1.05E-01 C-type lectin domain family 4, member e
micall2 1.1 2.59E-01 1.3 2.05E-03 1.1 6.47E-02 MICAL-like 2
plagl2 1.1 1.36E-01 1.2 5.22E-03 1.1 1.67E-01 pleiomorphic adenoma gene-like 2
slc31a2 1.0 6.87E-01 1.3 7.77E-04 1.1 7.59E-02 Solute Carrier Family 31 (Copper Transporter), Member 21
tug1 1.0 8.76E-01 1.1 8.88E-01 1.1 7.83E-01 taurine upregulated gene 1
csf1 1.4 8.84E-03 1.5 7.07E-04 1.0 5.99E-01 colony stimulating factor 1
tmem132e 1.2 1.94E-02 1.2 4.67E-03 1.0 8.93E-01 transmembrane protein 132E
(Continued)
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fold change across 4|24|48 hours were seen in IL-1 (interleukin-1- α and β, 2.4|3.3|4.3 fold and
5.2|4.1|10.7 fold); and FPR2 (formyl peptide receptor 2, 2.7|3.5|6.8 fold). Chemokines CXCL2
and CCL3 were also up-regulated (chemokine C-X-C motif ligand 2, 2.5|1.4|2.8 fold; chemo-
kine C-C motif ligand 3, 2.8|2.3|2.4 fold). Only 2 genes were shown to be down-regulated over
the time course due to the presence of SEA, this included PLD4 and LPL (phospholipase D 4,
1.1|1.3|-2.0 fold and lipoprotein lipase 1.5|-2.5|-5.2 fold).
In addition to the genes identified by t-tests, novel genes were also identified using either a 2
fold cut off or due to their known action in the host immune system or in tissue remodeling
(Table 2). A variety of chemokines were evident including CCL2 & 7, CXCL1 & 16, and cyto-
kines IL 6, 10 & 11, while genes associated with extracellular matrix degradation included
MMP 3, 9, 10 & 13, and TIMP 1. Generally, all genes were up-regulated (Table 2) with differen-
tial expression increasing with time over the 48hrs in culture with the addition of SEA. Genes
related directly to collagen deposition were generally unchanged in the presence of SEA with
moderate (<1.4 fold) up-regulation observed at 48hrs in culture (S2 Table). Some genes were
down-regulated during the time course such as AQP1 (aquaporin 1, -3.1 fold at 24hrs); LPL (li-
poprotein lipase, -5.2 fold at 48hrs); EAR2 (eosinophil-associated ribonuclease A family mem-
ber 2, -3.5 fold at 48hrs); and VSIG4 (V-set and immunoglobulin domain containing 4, -4 fold
at 48hrs) (See S2 Table).
Pathway analysis
To better appreciate the broader biological significance of the 48 genes identified as differen-
tially expressed in the presence of SEA, Ingenuity Pathway Analysis (IPA) was undertaken.
Presented in Table 3, the top 20 canonical pathways based on p-value, included those related to
granulocyte, macrophage and hepatic stellate cell activity. Immunological activities were asso-
ciated with cytokine production and IL-10 and IL-17, and broad terms including acute phase
and communication between innate and adaptive responses. Gene pathways of liver specific
functions modulated by SEA including cholestasis and liver X receptor (LXR) signalling were
also identified. A complete summary of the entire IPA analysis, including all canonical path-
ways (126) identified, upstream regulators, networks, toxicity lists and specific molecules, is
presented in S3 Table.
Real-time PCR validation of microarray findings
To validate the microarray findings, a subset of nine genes was analysed using qPCR. The rela-
tive fold change of gene expression determined by microarray analysis and qPCR were overall
similar for the majority of data points for all nine genes and three time points (Fig 3, Tables 1
and 2). The microarray and qPCR data for the nine genes showed a significant correlation (-α
= 0.05) between the two methods (Spearman’s Rho = 0.9435, P value =<0.0001, n = 27),
Table 1. (Continued)
FC SEA / control (hours)
Symbol 4 p-Value 24 p-Value 48 p-Value Deﬁnition
pld4 1.1 4.52E-02 1.3 6.23E-04 -2.0 5.35E-08 phospholipase D family, member 4
lpl 1.5 3.20E-03 -2.5 2.93E-06 -5.2 1.82E-12 lipoprotein lipase
Gene expression (fold change; FC), with associated p-values, relative to control tissues in the ex vivo native mouse liver model over 48 hours after the
addition of SEA determined using t-tests with multiple testing correction p0.05 (Benjamin-Hochberg).
doi:10.1371/journal.pntd.0003760.t001
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indicating considerable support for the results obtained by the microarray analysis. The major
difference noted between the qPCR and microarray findings was the down-regulation of
COL1a1 (collagen type I -α 1) (-4.5 fold) in the presence of SEA at 24hrs; however by 48hrs
this decrease had changed to a moderate (1.6 fold) but significant (p value 0.01) increase in
gene expression (Fig 3).
Detection of chemokines and cytokines in culture supernatant
To further validate the microarray findings, the culture supernatants were assessed for a subset
of 13 chemokines and 13 cytokines using multi-analyte flow assays. Seven proteins were de-
tected in the culture supernatant and all were shown to be differentially expressed between
SEA-treated and untreated samples (Fig 4). Of the thirteen cytokines measured, only IL-6 was
Table 2. Novel differentially expressed genes in response to S. japonicum soluble egg antigen (SEA).
FC SEA / control (hours)
Symbol 4 p-Value 24 p-Value 48 p-Value Deﬁnition
angpt2 -3.1 1.20E-05 1 9.96E-01 1.1 1.00E+00 angiopoietin 2
aqp1 1 4.78E-01 -3 1.40E-04 -2.3 2.80E-03 aquaporin 1
ccl2 1.8 9.19E-03 1.7 1.47E-02 1.3 1.00E+00 chemokine (C-C motif) ligand 2
ccl7 1.1 6.38E-01 1.8 3.38E-02 1.7 1.00E+00 chemokine (C-C motif) ligand 7
ccrl2 1.4 1.44E-02 1.5 1.14E-02 1.2 1.00E+00 chemokine (C-C motif) receptor-like 2
cd14 1.3 1.07E-01 1.2 1.70E-01 1.9 6.04E-04 CD14 antigen
col1a1 -1.1 2.65E-01 -1.1 2.61E-01 1.4 6.64E-03 procollagen, type I, alpha 1
col5a1 1.1 3.80E-01 1 8.40E-01 1.7 3.41E-01 procollagen, type V, alpha 1
cxcl1 1.1 2.60E-01 1 7.51E-01 2.2 2.30E-05 chemokine (C-X-C motif) ligand 1
cxcl16 1.6 2.10E-03 1.5 3.18E-04 1.3 9.30E-01 chemokine (C-X-C motif) ligand 16
fstl1 1 8.81E-01 -1.1 2.61E-01 1.7 1.26E-01 follistatin-like 1
iﬁt3 -1.2 4.36E-01 2.3 3.09E-02 1 1.00E+00 interferon-induced protein with tetratricopeptide repeats 3.
iigp2 -1.5 1.91E-03 1.8 1.74E-06 1.1 1.00E+00 interferon inducible GTPase 2
il10 1.9 6.79E-08 1.2 4.53E-03 1.2 1.00E+00 interleukin 10
il11 -1.3 8.55E-02 -1.2 3.57E-01 2.4 1.06E-04 interleukin 11
il4i1 1.8 1.09E-06 1.2 3.72E-03 1.3 9.75E-01 interleukin 4 induced 1
il6 -1.1 3.87E-01 1 9.50E-01 2.3 4.17E-03 interleukin 6
irak3 1.3 8.93E-03 1.8 9.76E-05 2.6 3.34E-05 interleukin-1 receptor-associated kinase 3
loc100044702 -1.2 2.05E-01 1.1 5.54E-01 2.7 4.19E-03 similar to LPS-induced CXC chemokine.
ly6a -1.4 3.47E-03 2.1 7.11E-04 1 1.00E+00 lymphocyte antigen 6 complex, locus A
mmp10 1 7.21E-01 1.3 1.06E-01 1.8 1.00E+00 matrix metallopeptidase 10
mmp3 1 9.65E-01 -1.1 7.73E-01 1.7 7.94E-02 matrix metallopeptidase 3
mmp9 1 6.94E-01 1.4 1.14E-01 2.1 3.44E-03 matrix metallopeptidase 9
pglyrp1 -1.1 3.78E-01 1.2 1.24E-02 1.7 3.12E-03 Peptidoglycan recognition protein
serpinb2 1.1 1.11E-01 1.1 5.22E-01 2.5 4.89E-05 serine (or cysteine) peptidase inhibitor, clade B, member 2.
sod2 1 9.87E-01 1.2 3.69E-02 1.8 9.06E-03 Superoxide dismutase 2, mitochondrial
timp1 -1.1 7.66E-01 -1.1 5.10E-01 2.1 2.76E-03 tissue inhibitor of metalloproteinase 1
tnc 1 6.29E-01 -1.2 1.28E-01 2.3 9.88E-02 tenascin C
tnf 1.9 2.27E-04 1.3 3.90E-03 1.2 1.00E+00 tumor necrosis facto
tlr4 -1.1 1.94E-01 1 9.19E-01 1 1.00E+00 toll-like receptor 4
Gene expression fold changes (FC) with associated p-value, relative to control tissue in ex vivo native mouse liver model over 48 hours after the addition
of SEA. Genes with known roles in immune responses or tissue remodeling are shown.
doi:10.1371/journal.pntd.0003760.t002
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detected in the culture supernatant at 24 and 48 hours post treatment. Significantly more IL-6
was measured in SEA-treated groups at 48 hours when compared with untreated groups,
which correlated with the transcriptional data obtained. Chemokines CXCL1, CCL2 and
CXCL5 were detected in culture supernatants from both SEA-treated and untreated liver sam-
ples, with elevated expression of these proinflammatory molecules after SEA treatment, as ob-
served in the differential gene expression measured by microarray (Table 2). Detectable levels
of CCL3, CCL4 and CCL22 were measured only in the supernatant of SEA-treated liver
Table 3. Top 20 pathways identified by Ingenuity Pathway Analysis.
Ingenuity Canonical Pathways P-
value
Genes
Granulocyte Adhesion and Diapedesis 4.37E-
09
CXCL3, IL1A, CCL4, FPR2, CCL3L1/
CCL3L3, MMP13, IL1B, FPR1
Atherosclerosis Signaling 9.55E-
09
IL1A, CD40, CSF1, LPL, MMP13,
IL1B, S100A8
Role of Macrophages, Fibroblasts and Endothelial Cells
in Rheumatoid Arthritis
2.04E-
08
TLR2, IL1A, CSF1, MMP13, OSM,
IL1B, IRAK3, TCF7L2, TRAF1
Communication between Innate and Adaptive Immune
Cells
5.13E-
08
TLR2, IL1A, CCL4, CD40, CCL3L1/
CCL3L3, IL1B
Hepatic Fibrosis / Hepatic Stellate Cell Activation 6.46E-
07
CXCL3, IL1A, CD40, CSF1, MMP13,
IL1B
Altered T Cell and B Cell Signaling in Rheumatoid
Arthritis
1.35E-
06
TLR2, IL1A, CD40, CSF1, IL1B
NF-Î°B Signaling 2.29E-
06
TLR2, IL1A, TNIP1, CD40, IL1B,
IRAK3
Agranulocyte Adhesion and Diapedesis 3.39E-
06
CXCL3, IL1A, CCL4, CCL3L1/
CCL3L3, MMP13, IL1B
LXR/RXR Activation 7.41E-
06
IL1A, LPL, IL1B, S100A8, ARG2
Differential Regulation of Cytokine Production in
Intestinal Epithelial Cells by IL-17A and IL-17F
1.82E-
05
IL1A, CCL4, IL1B
TREM1 Signaling 2.40E-
05
TLR2, CXCL3, CD40, IL1B
Role of Osteoblasts, Osteoclasts and Chondrocytes in
Rheumatoid Arthritis
1.29E-
04
IL1A, CSF1, MMP13, IL1B, TCF7L2
Role of Hypercytokinemia/hyperchemokinemia in the
Pathogenesis of Inﬂuenza
1.32E-
04
IL1A, CCL4, IL1B
Role of IL-17F in Allergic Inﬂammatory Airway Diseases 1.41E-
04
CCL4, MMP13, IL1B
Hepatic Cholestasis 2.63E-
04
IL1A, SLCO3A1, IL1B, IRAK3
Toll-like Receptor Signaling 2.69E-
04
TLR2, IRAK3, TRAF1
Role of IL-17A in Psoriasis 3.80E-
04
CXCL3, S100A8
IL-10 Signaling 4.79E-
04
IL1A, IL1B, ARG2
Acute Phase Response Signaling 5.50E-
04
IL1A, Saa3, OSM, IL1B
Dendritic Cell Maturation 6.76E-
04
TLR2, IL1A, CD40, IL1B
From the 48 differentially expressed genes in response to S. japonicum soluble egg antigen in the ex vivo
native mouse liver model over 48 hours.
doi:10.1371/journal.pntd.0003760.t003
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sections. These finding mirrored observed increases in gene expression for these molecules in
the microarray analysis (Table 1). The close correlation of protein measurement in the super-
natants with the gene expression data from the microarray supports the validity of
our findings.
Discussion
The precision cut liver slice (PCLS) mouse model [17] is a novel approach to study schistoso-
miasis that uniquely allows the investigation of the early local responses of a mixture of resi-
dential hepatic cells (hepatic stellate cells—HSCs, hepatocytes and KCs etc) to soluble
molecules released by dying schistosome eggs. Using this system we have shown how early mo-
lecular events contribute to the eventual granulomatous response that takes place in the liver of
the S. japonicum infected definitive host. We consider our findings represent the early interac-
tion of dying schistosome eggs, and the release of all of their soluble protein (SEA) into the
host liver microenvironment. There is, however, a much longer process that leads to granuloma
formation [1,3], involving non-residential cell recruitment and cytokine signalling, and eventu-
al chronic disease. As such, in vivo studies are necessary to follow disease progression over the
time period that follows.
Fig 3. Real time validation of a subset of the 13,746 genes.Genes were identified both as differentially expressed and unchanged due to the presence of
soluble egg antigen (SEA) from Schistosoma japonicum. Relative gene expression was normalised to the house keeping gene HPRT. Time points refer to
pre-cut intact tissue (PC) and tissue slices in culture before (0) and after (4, 24 and 48 hours) the addition of soluble egg antigen (SEA). P values = *0.05,
**0.01, ****0.0001.
doi:10.1371/journal.pntd.0003760.g003
An Ex VivoModel for Hepatic Schistosomiasis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003760 May 12, 2015 11 / 19
These ex vivo observations, build on our previously published in vivo studies using tran-
scriptional profiling of naturally infected whole livers [2,28]. Furthermore, these in vivo results
identified the contribution of hepatic immune cell types in the resulting granuloma formation
in host liver, and shed light on the initial molecular interaction between parasite antigen and
Fig 4. Cytokine and chemokine levels were determined in liver section culture supernatants. Using
Legendplex multi-analyte flow assay kits, IL-6, CXCL1, CCL2, CCL3, CCL4, CXCL5 and CCL22 were
detected. Levels of significance were calculated using two-way ANOVA with Sidaks multiple comparison test.
P values = *0.05, **0.01, ****0.0001, NS = not significant >0.05.
doi:10.1371/journal.pntd.0003760.g004
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residential hepatic cells. The MDA concentration in the media of PCLS did not increase due to
the presence of SEA, but did increase during the 48hrs in culture. However the increase seen is
comparable to previous studies where other related liver enzymes were measured and controls
increased between 1.5 and 3 fold over a similar period in culture [29]. One potential improve-
ment to our ex vivomodel that could enhance the fidelity of the tissues, would be the use of
hyper-oxygenation to the culture conditions using specialised equipment [30]. The use of hy-
perbaric culture conditions could also be considered as these have protective properties in re-
ducing mitochondrial damage [31]. The impact of oxidative stress on hepatic pathology and
immunology may be a factor and while the ex vivo conditions we utilised were sub-optimal,
they have provided an avenue to investigate hepatic schistosomiasis in a complex tissue model
that is a considerable improvement on traditional in vivo studies, being able to synchronise the
delivery of parasite antigen to liver tissue.
PCLS have been successfully employed in studies of liver metabolism and toxicity [18]. Fi-
brosis has also been investigated using PCLS, predominantly using chemical or surgical meth-
ods [18]. The application of an ex vivomodel to investigate tissue remodeling in the liver in
response to a major human pathogen, is a novel approach.
While schistosome eggs that lodge in the liver of hosts produce extensive fibrotic granulo-
ma, no fibrosis is evident local to the egg [1–3,22]. When exposed to schistosome eggs, the pro-
fibrogenic phenotype of a human HSC line (LX-2 cells) is blocked, i.e., collagen production is
switched off and a state of quiescence is induced [12,13]. This demonstrates that schistosome
eggs produce mediators with potent and novel anti-fibrotic activity on the major collagen pro-
ducing cells of the liver. Our observation by qPCR of a decrease in Col1A1 in the presence of
SEA supports this observation.
One of the highest up-regulated genes identified was serum amyloid A 3 (SAA3) which has
been linked previously to liver disease [32]. The expression of SAA3 has been associated with
the metastasis of cancer cells and a corresponding influx of immune cells [33]. Proteins of the
SAA family, including SAA3, have been shown to enhance the expression of a number of
proinflammatory proteins such as S100a8, and various matrix metalloproteinases (MMPs)
[33]. Furthermore, other studies have linked SAA to formyl peptide receptor [34] and this also
drives the expression of MMPs, while the SAA inflammation pathway mediates IL-1-β secre-
tion [35]. Proinflammatory S100a8, IL-1-β and FPR2, and the tissue remodeling MMP3, 9, 13
were all up-regulated in the ex vivomodel we used, supporting these potential
molecular mechanisms.
As shown in mouse models of liver damage, the TLR2/S100A9/CXCL-2 signaling network
drives neutrophil recruitment [36]. CXCL2 has been shown in low concentrations to provide
protection against cell death, while at higher levels it induces apoptosis in hepatocytes [37].
The elevation of TLR2, CXCL-2 and S100A8, with the latter originally demonstrated using the
knockout of S100A9 which leads to S100A8 protein instability, suggests that the earliest expo-
sure of parasite antigen leads to the recruitment of neutrophils to the liver. This mirrors the
well reported neutrophilic nature of hepatic granulomas that are distinctive in infections of S.
japonicum while absent from those of S.mansoni [2,22,38]. However, in our ex vivo system the
exclusion of circulatory cells allows us to focus clearly on residential cells, including those asso-
ciated with the innate immune system. In addition to the previously mentioned role in MMP
expression, the elevation of FPR2 may also increase neutrophil recruitment since the release of
a related formyl peptide receptor (FPR1) from necrotic tissues appears distinct from the func-
tion of CXCL family of chemokines ([39], and reviewed in [40]).
The observed up-regulation of various MMPs in our ex vivo system may be in response to
the corresponding up-regulation of TNC (Tenascin-C). TNC is an extracellular matrix protein
associated with cellular adhesion having a direct interaction with fibronectin, and results in the
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up-regulation of MMPs [41]. However, the temporal expression of TNC and MMPs did not
clearly demonstrate their relationship since TNC was only elevated at 48 hrs while MMP 9&10
were both increased at 24hrs (see Table 2). Additional study and validation of the transcrip-
tional and protein levels of these genes in response to schistosome antigens will further our un-
derstanding of their importance in tissue remodeling during hepatic schistosomiasis. In our
study, other indicators of tissue hepatic remodeling is seen in the decrease in AQP1 expression,
-3 fold after 24hrs and -2.3 fold after 48hrs. Aquaporin 1 is expressed in proliferating bile ducts
[42] however reduced levels are associated with intrahepatic cholestasis, and a decrease in bile
flow. A feature of hepatic schistosomiasis is the decrease in bile flow [43] and the decrease in
AQP1 expression we observed ex vivomay mirror the in vivo clinical setting.
Interleukin 1 (IL-1-β and IL-1-α) had amongst the largest increase in gene expression over
the 48hrs after SEA exposure of liver slices in culture. Proinflammatory cytokines such as IL-1
are primarily expressed in the liver by monocytes, KCs and peripheral neutrophils. Increases in
cellular stress in hepatocytes can induce necrosis, which leads to the expression of IL-1-α [44]
and the activation of KCs which themselves produce IL-6. Thus, the elevated IL-1-β and IL-1-α
observed in our system were particularly striking due to the exclusion of recruited leukocytes
in our ex vivomodel.
The observed correlation of chemokines and cytokines measured in the culture superna-
tants with the gene expression data collected in the microarray supports our gene expression
data. The observation of an increase in only one (IL-6) of the 13 cytokines investigated is not
surprising in the context of our infection model. As the liver tissue was harvested from unin-
fected animals and then isolated in an ex vivo culture system, the likelihood of detecting T cell
derived cytokines was minimal. Any T cells would first need to be activated by antigen specifi-
cally and migrate into the tissue before producing measurable cytokine. The detection of IL-6
demonstrates a robust response to immune assault; IL-6 is produced by various cell types, such
as endothelial cells and fibroblasts, and can be secreted by macrophages in response to PAMPs
(pathogen associated molecular patterns). The early inflammatory cytokines IL-1-α and IL-1-β
are known to induce up-regulation of IL-6 and they were shown to have strongly increased ex-
pression from as early as 4hrs post SEA exposure (Table 1 and Fig 3).
Inflammatory macrophages and also TLR4 activated HSCs release the chemokines CCl3
(2.8|2.3|2.4; fold changes at 4hrs, 24hrs, 48hrs), Ccl4 (2.0|1.5|1.6), which acts on hepatic stellate
cell proliferation [45], and recruitment of KCs [46], leukocytes and monocytes [47] to regions
of cellular damage. We were able to directly measure CCL3 and CCL4 among other proinflam-
matory cytokines in culture supernatants. The increased levels of proinflammatory chemokines
reflect a strong response to SEA, with the induced chemokines having important roles in the
trafficking and recruitment of immune cells. The strong up-regulation of these proinflamma-
tory chemokines, early after SEA exposure, demonstrates that SEA induces clear danger signals
in resident liver cells, which in turn drive the recruitment of the specialised immune cells re-
quired to form the granulomatous lesions that will eventually encase schistosome eggs in
an infection.
Activated macrophages produce TNF-α (1.9 fold at 4hrs) and IL-1 (consistently up-regulat-
ed across time course) that in turn activate fibroblasts and induce overproduction of ECM pro-
teins (1.2 fold at 4hrs, 1.4 fold at 24hrs, and 1.7 fold at 48hrs). TNF-α-triggered (1.9 fold at
4hrs) signal transduction leading to the expression of fibrogenic responses.
Activation of KCs in our ex vivomodel was reflected in the up-regulation of TNF (1.9|1.3|
1.2), IL6, IL1 and CD40 (1.6|1.5|1.3). IRAK (interleukin-1 receptor-associated kinase) is a fami-
ly of genes encoding proteins which are important components of immune signal transduction
pathways [48]. Associated with Toll/IL-R signalling, IRAKs are expressed primarily in mono-
cytes and macrophages and act as negative regulators. The CD14-TLR2-IRAK4 complex is
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associated with KC when LPS triggers TLR4 signaling which resulted in the production of TNF
(1.9 fold at 4 h), IL-1b (4.1|5.2|10.7), IL-6 (-1.1|1|2.3), IL-12 (not detected), IL-18 (unchanged),
and IL-10 (1.9|1.2|1.2) [49]. In our experiments, CD14 (1.9 fold) and TLR2 (1.8 fold) were
both up-regulated after 48hrs but IRAK4 was unchanged. KCs also express TLR2 (1.4|1.4|1.8),
TLR3, and TLR9 [50], with the latter two genes not presenting any detectable expression in our
microarray analysis of liver slices exposed to SEA. While IRAK4 (and IRAK1&2) was un-
changed in our experiments, the related gene IRAK3 was up-regulated 2.6 fold at 48 h. IRAK3
(IRAK-M), unlike IRAK1,2 and 4 has limited capacity to act in pro-inflammatory complexes,
but instead acts as a negative regulator acting on IRAK1 and 2 disrupting their complex forma-
tion, and effectively reducing downstream inflammatory mechanisms [48]. Again our ex vivo
model reflected the gene expression of predominantly residential cells of the liver, with only
the presence of basal amounts of circulating cells present in the processing of precision cut
liver slices.
There were indications of the presentation of antigen in the exposure of liver slices to SEA.
This was reflected in the up-regulation of the following genes: CCL4, CD40, CLEC4E, CSF1,
CXCL3, IL1B, OSM and TLR2, all of which are associated with the recruitment of antigen pre-
senting cells (as identified by IPA; see S3 Table). The release of CCL3 (2.9|2.4|2.5) has been re-
ported in KCs to recruit dendritic cells [51], which suggests a potential mechanism that SEA
induces in the residential cells in our ex vivomodel.
The early increase in MMP13 gene expression at 4hrs which decreased over time (5|1.9|1.3),
coupled with the opposite expression of TIMP1 which was unchanged at 4 and 24hrs and then
increased at 24hrs (-1.1|-1.1|2.1) may explain the decrease in collagen deposition which was
observed in the direct core of schistosome-induced granuloma. The initial exposure to SEA led
to reduced TIMP1 and increased MMP13, which would limit fibrosis deposition. The increase
in TIMP1 observed at the latest time point mirrors the clinical situation where elevated levels
are associated with hepatic fibrosis due to schistosomiasis japonica in supernatents of patient
PBMCs (peripheral blood mononuclear cells) stimulated with schistosome egg antigen [52].
TIMP1 was also elevated in experiments using trophoblast cells co-cultured with plasma from
pregnant women with schistosomiasis history or direct stimulation with SEA [53]. These inves-
tigations and a subsequent study of neonatal cord blood [54], demonstrate that schistosome
egg antigens induce a pro-inflammatory response during pregnancy and in newborns of schis-
tosome infected mothers. No correlation of MMPs (MMP1) with the development of hepatic
fibrosis was evident in the PBMC study [52], but the cord blood analysis did show significant
increases in the production of MMP2 during fibrosis [54]. This work and our observations in
naïve liver tissue exposed to SEA demonstrate the importance of inflammatory responses and
tissue remodeling markers in schistosomiasis, both at the primary site of pathology and, sys-
temically, especially during pregnancy.
We propose that the ex vivomodel we have employed represents well the interaction be-
tween liver cells and the release of SEA that occurs when schistosome eggs are deposited in vivo
and subsequently die. Our transcription data obtained from ex vivomaintained tissue supports
this correlation with the in vivo situation when we consider our previously published findings
[22]. In the previous study we used laser microscopy microdissection (LMM) to isolate specific
regions within and proximal to the granuloma formed in the livers of infected S. japonicum
mice. However it must be noted that in vivo granuloma formation following the deposition of
parasite eggs and the release of SEA, would be accompanied by the influx of peripheral cells, a
feature that is not present in the ex vivomodel. However despite these clear differences between
models, many genes were up-regulated in both studies including those associated with acute in-
flammation, such as SAA3, Type-1 genes, such as IL1-α, CCL4, CXCL2 and Type-17 genes,
such as IL6, IL1-β, CCL3.
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While this study has utilised naïve wild type mouse liver tissue, the future value of this
model could lie in the use of transgenic or cell depleted host tissue, to better define the specific
components of the residential cells that lead to inflammation, antigen presentation and fibrosis
in response to SEA. Further studies could focus also on the effect on the ex vivomodel using
earlier released schistosome proteins in egg ES (excretory/secretory) products. These can be
readily collected from the media of isolated and then cultured live parasite eggs. This subset of
schistosome egg proteins would represent the very first stages of egg deposition in the liver of
the host, demonstrating the interaction the hepatic environment has with live schistosome
eggs. Our findings provide a unique snapshot of the earliest phases of hepatic schistosomiasis,
where resident hepatic cells are first exposed to parasite egg antigen (SEA). Further, the find-
ings from this ex vivo approach have far reaching potential consequences in other hepatic pa-
thologies defined by fibrosis including alcoholic cirrhosis and viral infections.
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